Literature DB >> 31358389

Usefulness of Routine Lyme Screening in Patients with Uveitis.

Sonny Caplash1, Sapna Gangaputra2, Natasha Kesav1, Marib Akanda1, Susan Vitale1, Shilpa Kodati1, Adriana Marques3, H Nida Sen4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31358389      PMCID: PMC6875618          DOI: 10.1016/j.ophtha.2019.06.014

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  4 in total

1.  Prevalence of Lyme disease among patients with uveitis.

Authors:  J T Rosenbaum; D W Rahn
Journal:  Am J Ophthalmol       Date:  1991-10-15       Impact factor: 5.258

2.  Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-11       Impact factor: 17.586

3.  A phylogenomic and molecular marker based proposal for the division of the genus Borrelia into two genera: the emended genus Borrelia containing only the members of the relapsing fever Borrelia, and the genus Borreliella gen. nov. containing the members of the Lyme disease Borrelia (Borrelia burgdorferi sensu lato complex).

Authors:  Mobolaji Adeolu; Radhey S Gupta
Journal:  Antonie Van Leeuwenhoek       Date:  2014-04-18       Impact factor: 2.271

4.  Lyme disease testing by large commercial laboratories in the United States.

Authors:  Alison F Hinckley; Neeta P Connally; James I Meek; Barbara J Johnson; Melissa M Kemperman; Katherine A Feldman; Jennifer L White; Paul S Mead
Journal:  Clin Infect Dis       Date:  2014-05-30       Impact factor: 9.079

  4 in total
  3 in total

1.  Classification Criteria for Intermediate Uveitis, Non-Pars Planitis Type.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-09       Impact factor: 5.488

2.  Classification Criteria For Pars Planitis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-04-15       Impact factor: 5.488

3.  Classification Criteria for Multiple Sclerosis-Associated Intermediate Uveitis.

Authors: 
Journal:  Am J Ophthalmol       Date:  2021-05-11       Impact factor: 5.488

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.